Pa. High Court Jettisons Wyeth's $9M Prempro Appeal

Law360, New York (December 16, 2013, 7:53 PM EST) -- The Pennsylvania Supreme Court on Monday dismissed a set of appeals launched by Wyeth Pharmaceuticals Inc. to avoid $8.6 million in punitive damages in a suit that claimed its Prempro menopause drug had caused a woman's breast cancer, saying it shouldn't have taken the cases.

Wyeth had asked the Pennsylvania high court last September to overturn the punitive damages award, arguing that it was invalidated by the U.S. Food and Drug Administration’s approval of the drug. The pharmaceutical company contended that the appeals court had erred...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.